Allergen exposure chambers: harmonizing current concepts and projecting the needs for the future – an <scp>EAACI</scp> Position PaperOliver Pfaar, Pascal Demoly, Jens M. Hohlfeld et al.|Allergy|2017Cited by 97
Safety, tolerability, and immunogenicity of an adult pneumococcal conjugate vaccine, V116 (STRIDE-3): a randomised, double-blind, active comparator controlled, international phase 3 trialHeather Platt, Christopher Galloway, Christopher Bruno et al.|The Lancet Infectious Diseases|2024Cited by 59
Clinical standardization of two controlled allergen challenge facilitiesAnne K. Ellis, Cynthia Rather, Robert L. Jacobs et al.|Annals of Allergy Asthma & Immunology|2019Cited by 12
Repetitive aeroallergen challenges elucidate maladaptive epithelial and inflammatory traits that underpin allergic airway diseasesAlisha M. Smith, Sunil K. Ahuja, Nathan Harper et al.|Journal of Allergy and Clinical Immunology|2021Cited by 10
Large‐scale provocation studies identify maladaptive responses to ubiquitous aeroallergens as a correlate of severe allergic rhinoconjunctivitis and asthmaAlisha M. Smith, Sunil K. Ahuja, Robert M. Ramirez et al.|Allergy|2021Cited by 10